Abstract:Although advancements in the preventive and therapeutic strategies of cardiac diseases have successfully improved the prognosis of many types of cardiac diseases, they are still challengeable targets because of their high mortality and large medical expenses. Moreover, because heart function is tightly associated with quality of life, it is important to elucidate the genetic and molecular basis of disease progression. One of the recent advances for assessing protein function is reverse chemical genetics, which has the advantages that complement classical reverse genetics and should advance efforts at drug discovery for many diseases. Toward that end an appropriate biological assay system is required to describe specific heart phenotypes. Recent studies have shown that many aspects of Drosophila heart development and function are similar to those observed in the human heart, making Drosophila a useful model system with the advantage of a simpler genetic organization and shorter life span. Here we describe several assay systems that can be used to characterize Drosophila heart function. The first method is an external electrical pacing assay that is used to assess the response to stress in the adult fly. The incidence of pacing-induced heart dysfunction measured by this method strongly correlates with natural aging and mutation in genes known to be involved in human cardiac dysfunction. Consequently, this method can be used to identify unapparent heart failure phenotypes. This procedure is applicable for both genetic and pharmacological screening. The second method is an image-based heart performance assay. This method provides details of the dynamics of heart contraction in real time similar to clinical echocardiography. This method may be used for secondary drug screening as well as for more detailed analysis of the genetic and pharmacological phenotypes of Drosophila hearts.

Dual color optogenetic tool enables heart arrest, bradycardic, and tachycardic pacing in Drosophila melanogaster

Non-invasive red-light optogenetic control of Drosophila cardiac function

Arrhythmia caused by a Drosophila tropomyosin mutation is revealed using a novel optical coherence tomography instrument

The realization of optical cardiac pacing by optogenetics

Modulation of the cardiac pacemaker of Drosophila: cellular mechanisms

Conservation of cardiac L-type Ca2+ channels and their regulation in Drosophila: A novel genetically-pliable channelopathic model

Drug discovery through functional screening in the Drosophila heart

High-power pulsed electrochemiluminescence for optogenetic manipulation of Drosophila larval behaviour

Age-associated cardiac dysfunction in Drosophila melanogaster

Simultaneous Optical Pacing and Membrane Voltage Mapping in ChR2-Expressing Neonatal Rat Ventricular Myocyte Cultures

Sub-second multi-channel magnetic control of select neural circuits in behaving flies

Abstract 38: Simultaneous Optical Pacing and Optical Voltage Mapping in Optogenetic Neonatal Rat Ventricular Myocyte Cultures

Bidirectional optogenetic control of inhibitory neurons in freely-moving mice

Colocalized, bidirectional optogenetic modulations in freely behaving mice with a wireless dual-color optoelectronic probe

Hyperpolarization by activation of halorhodopsin results in enhanced synaptic transmission: Neuromuscular junction and CNS circuit

An in vivo technique for pharmacological manipulation of Drosophila brain during optical recording

Integration of Engineered "Spark-Cell" Spheroids for Optical Pacing of Cardiac Tissue.

Channelrhodopsin-2–XXL, a powerful optogenetic tool for low-light applications

Near-infrared Light Driven Tissue-Penetrating Cardiac Optogenetics Via Upconversion Nanoparticles in Vivo.

Rhodopsin optogenetic toolbox v2.0 for light-sensitive excitation and inhibition in Caenorhabditis elegans

Mechanical and Chemical Factors Required for Maintaining Cardiac Rhythm in Drosophila melanogaster Larva